Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron

DOI 10.1016/j.neuron.2010.08.044

Cited by (959)

Items 201–300 of 959

Human Sirtuin Regulators: The “Success” Stories
Alyson M. Curry, Dawanna S. White, Dickson Donu, Yana Cen · 2021 · Frontiers in Physiology
Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability
Silva, M. Catarina, Cheng, Chialin, Mair, Waltraud, Almeida, Sandra, Fong, Helen, Biswas, M. Helal U., Zhang, Zhijun, Huang, Yadong, Temple, Sally, Coppola, Giovanni et al. · 2016 · Stem Cell Reports
Dissecting systemic control of metabolism and aging in the NAD World: The importance of SIRT1 and NAMPT‐mediated NAD biosynthesis
Shin‐ichiro Imai · 2011 · FEBS Letters
Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration
Christiane Richter‐Landsberg, Janina Leyk · 2013 · Acta Neuropathologica
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders
Jessica Eira, Catarina Santos Silva, Mónica Mendes Sousa, Márcia A. Liz · 2016 · Progress in Neurobiology
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, Liviu‐Gabriel, Eckert, Anne, Ittner, Lars Matthias, Piguet, Olivier, Götz, Jürgen · 2016 · Journal of Neurochemistry
Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno Pietro Imbimbo, Madia Lozupone, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, Camilla Prete, Antonio Daniele et al. · 2016 · Immunotherapy
Neuroprotective effects of dietary restriction: Evidence and mechanisms
Pani, Giovambattista · 2015 · Seminars in Cell & Developmental Biology
ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Shibuya, Yohei, Chang, Catherine CY, Chang, Ta-Yuan · 2015 · Future Medicinal Chemistry
Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble TauIn Vivo
Tomáš Ondrejčák, Igor V. Klyubin, Grant T. Corbett, Graham Mathew Fraser, Wei Hong, Alexandra J. Mably, Matthew J. Gardener, Jayne Hammersley, Michael S. Perkinton, Andrew Billinton et al. · 2018 · Journal of Neuroscience
Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology
A. Raquel Esteves, A.M. Palma, R. Gomes, Daniel Santos, Diana Filipa Silva, Sandra M. Cardoso · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
Huiqin Zhang, Yu Cao, Lina Ma, Yun Wei, Hao Li · 2021 · Frontiers in Cell and Developmental Biology
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
Trzeciakiewicz, Hanna, Ajit, Deepa, Tseng, Jui-Heng, Chen, Youjun, Ajit, Aditi, Tabassum, Zarin, Lobrovich, Rebecca, Peterson, Claire, Riddick, Natallia V., Itano, Michelle S. et al. · 2020 · Nature Communications
Pathological Changes of Tau Related to Alzheimer’s Disease
Dandan Chu, Fei Liu · 2018 · ACS Chemical Neuroscience
Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration
Caio Henrique Mazucanti, João Victor Cabral‐Costa, Andréa Rodrigues Vasconcelos, Diana Zukas Andreotti, Cristóforo Scavone, Elisa Mitiko Kawamoto · 2015 · Current Topics in Medicinal Chemistry
Neuroprotective Sirtuin ratio reversed by ApoE4
Theendakara, Veena, Patent, Alexander, Peters Libeu, Clare A., Philpot, Brittany, Flores, Sonia, Descamps, Olivier, Poksay, Karen S., Zhang, Qiang, Cailing, Gabriellee, Hart, Matthew et al. · 2013 · Proceedings of the National Academy of Sciences
A BCL6/BCOR/SIRT1 Complex Triggers Neurogenesis and Suppresses Medulloblastoma by Repressing Sonic Hedgehog Signaling
Luca Tiberi, Jérôme Bonnefont, Jelle van den Ameele, Serge Daniel Le Bon, Adèle Herpoel, Angéline Bilheu, Beverly W. Baron, Pierre Vanderhaeghen · 2014 · Cancer Cell
Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture
Takashi Miyamoto, Liana Roberts Stein, Reuben Thomas, Biljana Djukic, Praveen Taneja, Joseph A. Knox, Keith A. Vossel, Lennart Mucke · 2017 · Molecular Neurodegeneration
Aggregation of Disordered Proteins Associated with Neurodegeneration
Phoebe S. Tsoi, My Diem Quan, Josephine C. Ferreon, Allan Chris M. Ferreon · 2023 · International Journal of Molecular Sciences
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, Keqiang Ye · 2024 · Translational Neurodegeneration
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Katryna K. Cisek, Grace Cooper, Carol J. Huseby, Jeff Kuret · 2014 · Current Alzheimer Research
Axonal Degeneration in AD: The Contribution of Aβ and Tau
Natalia Salvadores, Cristian Gerónimo‐Olvera, Felipe A. Court · 2020 · Frontiers in Aging Neuroscience
Targeting tau: clinical trials and novel therapeutic approaches
VandeVrede, Lawren, Boxer, Adam L., Polydoro, Manuela · 2020 · Neuroscience Letters
NEDD4-mediated HSF1 degradation underlies α-synucleinopathy
Eunhee Kim, Bin Wang, Namratha G. Sastry, Eliezer Masliah, Peter T. Nelson, Huaibin Cai, Francesca‐Fang Liao · 2015 · Human Molecular Genetics
Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases
Yuqing Zhang, Shailendra Anoopkumar‐Dukie, Devinder S Arora, Andrew Keith Davey · 2019 · European Journal of Pharmacology
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Michael S. Wolfe · 2012 · Scientifica
Upregulation of miR-181 Decreases c-Fos and SIRT-1 in the Hippocampus of 3xTg-AD Mice
Carlos J. Rodríguez‐Ortiz, David Baglietto‐Vargas, Hilda Martínez‐Coria, Frank M. LaFerla, Masashi Kitazawa · 2014 · Journal of Alzheimer s Disease
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies
Gibbons, Garrett S, Banks, Rachel A, Kim, Bumjin, Changolkar, Lakshmi, Riddle, Dawn M, Leight, Susan N, Irwin, David J, Trojanowski, John Q, Lee, Virginia M Y · 2018 · Journal of Neuropathology & Experimental Neurology
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Yanuar Alan Sulistio, Klaus Heese · 2015 · Molecular Neurobiology
Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo
Marianna Karina Gorsky, Sylvie Burnouf, Jacqueline Dols, Eckhard Mandelkow�, Linda Partridge · 2016 · Scientific Reports
Inhibition of JNK by a Peptide Inhibitor Reduces Traumatic Brain Injury–Induced Tauopathy in Transgenic Mice
Hien Tran, Laura Sanchez, David L. Brody · 2012 · Journal of Neuropathology & Experimental Neurology
Resveratrol and Alzheimer’s disease: message in a bottle on red wine and cognition
Alberto Granzotto, Paolo F. Zatta · 2014 · Frontiers in Aging Neuroscience
The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy
Chengcheng Zhang, Ang Xing, Meng‐Shan Tan, Lan Tan, Jin‐Tai Yu · 2015 · Molecular Neurobiology
Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance
Wang, Lisha, Bharti, Kumar, Rajnish, Pavlov, Pavel F., Winblad, Bengt · 2021 · European Journal of Medicinal Chemistry
Brain Activation of SIRT1: Role in Neuropathology
Alanna Fernandes Paraíso, Keila Lopes Mendes, Sérgio Henrique Sousa Santos · 2013 · Molecular Neurobiology
Research Progress on Alzheimer's Disease and Resveratrol
Yan Yan, Huihuang Yang, Yuxun Xie, Yuanlin Ding, Danli Kong, Haibing Yu · 2020 · Neurochemical Research
Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism
Luigi Formisano, Natascia Guida, Valeria Valsecchi, Maria Cantile, Ornella Cuomo, Antonio Vinciguerra, Giusy Laudati, Giuseppe Pignataro, Rossana Sirabella, Gianfranco Di Renzo et al. · 2015 · Journal of Neuroscience
Build-UPS and break-downs: metabolism impacts on proteostasis and aging
Franziska Ottens, André Franz, Thorsten Hoppe · 2021 · Cell Death and Differentiation
Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment
Rebecca B. Weinberg, Elliott Jay Mufson, Scott Counts · 2015 · Frontiers in Neuroscience
Paradoxical Enhancement of Fear Extinction Memory and Synaptic Plasticity by Inhibition of the Histone Acetyltransferase p300
Roger Marek, Carlos M. Coelho, R Sullivan, Danay Baker‐Andresen, Xiang Li, Vikram Singh Ratnu, Kevin J. Dudley, David J. Meyers, Chandrani Mukherjee, Philip A. Cole et al. · 2011 · Journal of Neuroscience
A novel mechanism of synaptic and cognitive impairments mediated via microRNA-30b in Alzheimer's disease
Yunping Song, Mei Hu, Jian Zhang, Zhao‐Qian Teng, Chu Chen · 2018 · EBioMedicine
Sirtuins: from metabolic regulation to brain aging
Wenzhen Duan · 2013 · Frontiers in Aging Neuroscience
Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neurons
Steven J. Greco, Ashkan Hamzelou, Jane M. Johnston, Mark A. Smith, John Wesson Ashford, Nikolaos Tezapsidis · 2011 · Biochemical and Biophysical Research Communications
Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein*
Atsushi Kuno, Yusuke S. Hori, Ryusuke Hosoda, Masaya Tanno, Tetsuji Miura, Kazuaki Shimamoto, Yoshiyuki Horio · 2013 · Journal of Biological Chemistry
Tau-induced neurodegeneration: mechanisms and targets
Cindy Beharry, Leah S. Cohen, Jing Di, Kawsar Ibrahim, Susan Briffa-Mirabella, Alejandra del C. Alonso · 2014 · Neuroscience Bulletin
Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
Hedl, Thomas J., San Gil, Rebecca, Cheng, Flora, Rayner, Stephanie L., Davidson, Jennilee M., De Luca, Alana, Villalva, Maria D., Ecroyd, Heath, Walker, Adam K., Lee, Albert · 2019 · Frontiers in Neuroscience
PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening
Jonathan B. Baell, Lori Ferrins, Hendrik Falk, George Nikolakopoulos · 2013 · Australian Journal of Chemistry
Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer’s disease-like pathology
Sarkar, S., Engler-Chiurazzi, E.B., Cavendish, J.Z., Povroznik, J.M., Russell, A.E., Quintana, D.D., Mathers, P.H., Simpkins, J.W. · 2019 · Brain Research
Cell-based Models To Investigate Tau Aggregation
Sungsu Lim, Md. Mamunul Haque, Do‐Hee Kim, Dong Jin Kim, Yun Kyung Kim · 2014 · Computational and Structural Biotechnology Journal
Epigenetic drug discovery for Alzheimer’s disease
Ramón Cacabelos, Clara Torrellas · 2014 · Expert Opinion on Drug Discovery
MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer’s disease
Qiong‐Bin Zhu, Unga A. Unmehopa, Koen Bossers, Yuting Hu, Ronald W. H. Verwer, Rawien A. Balesar, Juan Zhao, Ai‐Min Bao, Dick Frans Swaab · 2016 · Brain
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
M. Catarina Silva, Stephen J. Haggarty · 2020 · International Journal of Molecular Sciences
Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer’s Disease Mouse Models
Gloria Biella, Federica Fusco, Emanuele Nardo, Ottavia Bernocchi, Alessio Vittorio Colombo, Stefan F. Lichtenthaler, Gianluigi Forloni, Diego Albani · 2016 · Journal of Alzheimer s Disease
Understanding Epigenetics in the Neurodegeneration of Alzheimer’s Disease: SAMP8 Mouse Model
Christian Griñán‐Ferré, Rubén Corpas, Dolors Puigoriol‐Illamola, Verónica Palomera‐Ávalos, Coral Sanfeliu, Mercè Pallàs · 2018 · Journal of Alzheimer s Disease
Sirtuin 1 and Alzheimer's disease: An up-to-date review
Liara Rizzi, Matheus Roriz‐Cruz · 2018 · Neuropeptides
Clinical neuropathology practice guide 5-2013: markers of neuronal maturation
Harvey B. Sarnat · 2013 · Clinical Neuropathology
Tau and MAPT genetics in tauopathies and synucleinopathies
Etienne Léveillé, Owen A. Ross, Ziv Gan‐Or · 2021 · Parkinsonism & Related Disorders
Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi
Lailing Du, Jiazhao Xie, Xiangshu Cheng, Xiao-Hong Li, Fanli Kong, Xia Jiang, Zhiwei Ma, Jian‐Zhi Wang, Chen Chen, Xinwen Zhou · 2013 · AGE
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
Measho H. Abreha, Eric B. Dammer, Lingyan Ping, Tian Zhang, Duc Minh Duong, Marla Gearing, James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2018 · PROTEOMICS
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6
J.D. Osko, David W. Christianson · 2019 · Biochemistry
Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons
Parimala Narne, Vimal Pandey, Praveen Kumar Simhadri, Prakash Babu Phanithi · 2016 · Seminars in Cell and Developmental Biology
Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise
Marta Cosín‐Tomás, María Jesús Álvarez‐López, Sandra Sanchez‐Roige, Jaume F. Lalanza, Sergi Bayod, Coral Sanfeliu, Merce PallÃ s, Rosa Maria Escorihuela, Perla Kaliman · 2014 · Frontiers in Aging Neuroscience
Current directions in tau research: Highlights from Tau 2020
Claire E. Sexton, Heather M. Snyder, Dirk Beher, Adam L. Boxer, Patrick Brannelly, Jean‐Pierre Brion, Luc Buée, Angela M. Cacace, Gaël Chételat, Martin Citron et al. · 2021 · Alzheimer s & Dementia
Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
Anuradha Venkatramani, Dulal Panda · 2019 · International Journal of Biological Macromolecules
A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
Jie Zheng, Na Tian, Fei Liu, Yidian Zhang, Jingfen Su, Yang Gao, Mingmin Deng, Linyu Wei, Jingwang Ye, Honglian Li et al. · 2021 · Signal Transduction and Targeted Therapy
HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes
Monika Noack, Janina Leyk, Christiane Richter‐Landsberg · 2014 · Glia
Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
Xilin Wu, Juan Piña-Crespo, Yun‐wu Zhang, Xiaochun Chen, Huaxi Xu · 2017 · Chinese Medical Journal
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
Paola Gamba, Serena Giannelli, Erica Staurenghi, Gabriella Testa, Barbara Sottero, Fiorella Biasi, Giuseppe Poli, Gabriella Leonarduzzi · 2021 · Antioxidants
Analysis of in vivo turnover of tau in a mouse model of tauopathy
Kaoru Yamada, Tirth K. Patel, Katja Hochgräfe, Thomas E. Mahan, Hong Jiang, Floy R. Stewart, Eva‐Maria Mandelkow, David M. Holtzman · 2015 · Molecular Neurodegeneration
Sporadic inclusion-body myositis: Conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau
Valerie Askanas, W. King Engel · 2011 · La Presse Médicale
Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves micro RNA ‐195 down‐regulation
Lihua Sun, Tao Ban, Chengdi Liu, Qing‐Xin Chen, Xu Wang, Meiling Yan, Xueling Hu, Xiaolin Su, Yanan Bao, Linlin Sun et al. · 2015 · Journal of Neurochemistry
Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
Khalid Iqbal, Cheng‐Xin Gong, Fei Liu · 2014 · Expert Opinion on Therapeutic Targets
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Yale Duan, Suzhen Dong, Feng Gu, Yinghe Hu, Zheng Zhao · 2012 · Translational Neurodegeneration
The role of altered protein acetylation in neurodegenerative disease
Kabir, Fariha, Atkinson, Rachel, Cook, Anthony L., Phipps, Andrew James, King, Anna Elizabeth · 2023 · Frontiers in Aging Neuroscience
The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Brhane Teklebrhan Assefa, Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Meles Tekie Gidey · 2020 · BioMed Research International
Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
Ben Boyarko, VIVIAN Y. H. HOOK · 2021 · Frontiers in Neuroscience
Procyanidins and Alzheimer’s Disease
Siqi Zhao, Li Zhang, Chenlu Yang, Zhenghua Li, Shuang Rong · 2019 · Molecular Neurobiology
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Haiqiong Ye, Yue Han, Ping Li, Zhengding Su, Yongqi Huang · 2022 · Journal of Molecular Neuroscience
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
La Barbera, Livia, Mauri, Emanuele, D’Amelio, Marcello, Gori, Manuele · 2022 · Frontiers in Neuroscience
Non-lysine ubiquitylation: Doing things differently
Ian R. Kelsall · 2022 · Frontiers in Molecular Biosciences
Epigenetic Modulation of Adult Hippocampal Neurogenesis by Extremely Low-Frequency Electromagnetic Fields
Lucia Leone, Salvatore Fusco, Alessia Mastrodonato, Roberto Piacentini, Saviana Antonella Barbati, Salvatore Zaffina, Giovambattista Pani, Maria Vittoria Podda, Claudio Grassi · 2014 · Molecular Neurobiology
Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases
Joanna Gerszon, Aleksandra Rodacka, Mieczysław Puchała · 2014 · Postepy Biologii Komorki
Ordered Assembly of Tau Protein and Neurodegeneration
Michel Goedert, Maria Grazia Spillantini · 2019 · Advances in experimental medicine and biology
HDAC 6 at the Intersection of Neuroprotection and Neurodegeneration
Constantin van Outryve d’Ydewalle, Elke Bogaert, Ludo Van Den Bosch · 2012 · Traffic
Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
Julia E. Gerson, Diana Laura Castillo‐Carranza, Rakez Kayed · 2014 · ACS Chemical Neuroscience
Nuclear Magnetic Resonance Analysis of the Acetylation Pattern of the Neuronal Tau Protein
Amina Kamah, Isabelle Huvent, François‐Xavier Cantrelle, Haoling Qi, Guy M. Lippens, Isabelle Landrieu, Caroline Smet‐Nocca · 2014 · Biochemistry
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Seon Beom Song, Jin‐Sung Park, Gu June Chung, In Hye Lee, Eun Seong Hwang · 2019 · Metabolomics
Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System
Pavithra Chandramowlishwaran, Anitha Vijay, Daniel Abraham, Ge Li, Simon Musyoka Mwangi, Shanthi Srinivasan · 2020 · Frontiers in Neuroscience
Neuroprotective Effect of Astragaloside IV on Cerebral Ischemia/Reperfusion Injury Rats Through Sirt1/Mapt Pathway
Yi‐Hua Shi, Xile Zhang, Peng-Jie Ying, Ziqian Wu, Lele Lin, Wei Chen, Guo‐qing Zheng, Wenzong Zhu · 2021 · Frontiers in Pharmacology
HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity
Tsushima, Hanako, Emanuele, Marco, Polenghi, Alice, Esposito, Alessandro, Vassalli, Massimo, Barberis, Andrea, Difato, Francesco, Chieregatti, Evelina · 2015 · Nature Communications
The role of sirtuins in Alzheimer's disease
Rakhee Lalla, Gizem Dönmez · 2013 · Frontiers in Aging Neuroscience
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice
Tomohiro Umeda, Satomi Maekawa, Tetsuya Kimura, Akihiko Takashima, Takami Tomiyama, Hiroshi Mori · 2014 · Acta Neuropathologica
Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1
Chaudhuri, Amrita Datta, Yelamanchili, Sowmya V., Marcondes, Maria Cecilia G., Fox, Howard S. · 2013 · The FASEB Journal
Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
Tara E. Tracy, Li Gan · 2017 · BioEssays
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, John-Joseph Borg, František Dráfi · 2023 · Frontiers in Pharmacology
Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1
Mark Frederick McCarty, James J. DiNicolantonio, James Henry O’Keefe · 2015 · Medical Hypotheses
Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer’s disease brain
Ayaho Dan, Muneaki Takahashi, Masami Masuda‐Suzukake, Fuyuki Kametani, Takashi Nonaka, Hiromi Kondo, Haruhiko Akiyama, Takao Arai, David M. A. Mann, Yuko Saito et al. · 2013 · Acta Neuropathologica Communications
A Structural Ensemble of a Tau-Microtubule Complex Reveals Regulatory Tau Phosphorylation and Acetylation Mechanisms
Brotzakis, Z. Faidon, Lindstedt, Philip R., Taylor, Ross J., Rinauro, Dillon J., Gallagher, Nicholas C. T., Bernardes, Gonçalo J. L., Vendruscolo, Michele · 2021 · ACS Central Science
CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis
Nancy Bartolotti, Orly Lazarov · 2019 · Brain Behavior and Immunity
Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight
Syed Nasir Abbas Bukhari · 2022 · Antioxidants